Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q1 2024 · 10-Q
Revenue$18.54M$18.54M+19.4% vs Q1 2023 Net Income-$1.76M-$1.76MN/M vs Q1 2023 EPS Diluted-$0.21-$0.21N/M vs Q1 2023 Gross Profit$16,646,592+24.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Operating Cash Flow-$1,594,370N/M Free Cash Flowderived-$1,660,188N/M Margins · derivedGross margin89.8%+3.5 pt vs Q1 2023
Operating margin-8.3%−0.4 pt vs Q1 2023
Net margin-9.5%−1.9 pt vs Q1 2023
ended Mar 31, 2024 · filed May 13, 2024 · 43 d after period end